PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9148865-2 1997 The L-ALP from the sera of normal adults and various liver diseases was found to show different chromatographic behaviours on DSA affinity column with multiple peaks of ALP activity after the L-ALP was treated with neuraminidase to remove the terminal sialic acids on the sugar chain of L-ALP. Sugars 272-277 neuraminidase 1 Homo sapiens 215-228 10632536-7 2000 By ELISA using mucin in which the sugar chains were destroyed by neuraminidase or NaIO4 treatment, it was demonstrated that anti-mucin antibodies recognized the epitopes of either the sugar chain or the core protein exposed through destruction of the sugar chains. Sugars 34-39 neuraminidase 1 Homo sapiens 65-78 9425290-5 1997 The results of treatment with neuraminidase, in addition to the findings for the enzyme mentioned above, suggest hyaluronidase from carcinoma cells and serum hyaluronidase to differ in sugar chains and/or the core protein. Sugars 185-190 neuraminidase 1 Homo sapiens 30-43 9874196-1 1998 The neuraminidase of influenza virus is a surface glycoprotein that catalyzes the hydrolysis of glycosidic linkages between terminal sialic acids and adjacent sugar moieties. Sugars 159-164 neuraminidase 1 Homo sapiens 4-17 6189786-5 1983 The binding was not observed when fibronectin was pretreated with neuraminidase, suggesting that the sugar moieties of fibronectin are responsible for the affinity. Sugars 101-106 neuraminidase 1 Homo sapiens 66-79 2476036-8 1989 It contained 22.2 mg of sugar per 100 mg protein, and sialic acid at least expressed the activity of the epitope because the antigenic activity was decreased by neuraminidase treatment. Sugars 24-29 neuraminidase 1 Homo sapiens 161-174 3343973-9 1988 IgA1, treated with neuraminidase or not, but not the other human Igs, was also an excellent inhibitor of agglutination, being more powerful than the best sugars studied. Sugars 154-160 neuraminidase 1 Homo sapiens 19-32 3317219-2 1987 The antigenicity is associated with the sugar moiety since: a) trypsin digestion did not affect the antigenic determinant; b) pretreatment of the cells with beta-glucosidase, alpha-mannosidase and neuraminidase completely abolished antibody binding. Sugars 40-45 neuraminidase 1 Homo sapiens 197-210 2430922-5 1986 The reactivities of some of the CEAs with 2 out of 4 antibodies to sugar epitopes increased significantly after treatment of CEAs with neuraminidase. Sugars 67-72 neuraminidase 1 Homo sapiens 135-148 8154849-2 1994 Sialic acid was added to ALP sugar moieties by alpha 2,3- or 2,6-sialyltransferase treatment of the asialo-form ALP (neuraminidase-treated ALP). Sugars 29-34 neuraminidase 1 Homo sapiens 117-130 2067026-3 1991 The physiological role of this sugar is not clear, but neuraminidase, which specifically hydrolyzes sialic acid from the sarcolemma, has been found to increase calcium exchange, cause electrophysiological abnormalities, and enhance the transient (T) calcium current in cardiac myocytes. Sugars 31-36 neuraminidase 1 Homo sapiens 55-68 6319581-3 1984 Digestion studies with neuraminidase and oligosaccharidase have indicated that the molecule is heavily sialated with most of the sialic acid located on the O-linked sugars. Sugars 165-171 neuraminidase 1 Homo sapiens 23-36 6682730-4 1983 Further, growth of K-562 in tunicamycin (which inhibits N-linked glycosylations occurring through the lipid intermediate pathway) with or without subsequent treatment with the enzyme neuraminidase, markedly reduced cell surface expression of sugars monitored by lectin binding. Sugars 242-248 neuraminidase 1 Homo sapiens 183-196 7316970-4 1981 glycoprotein, were detected only after treating the myelin membrane with neuraminidase, N-acetylneuraminic acid is a terminal sugar residue in these glycoproteins. Sugars 126-131 neuraminidase 1 Homo sapiens 73-86 656062-4 1978 The proposed neuraminidase deficiency in I-cell disease is discussed in the light of its significance in influencing the final sugar sequence in the carbohydrate structure of the recognition site. Sugars 127-132 neuraminidase 1 Homo sapiens 13-26 1269409-0 1976 [Effect of neuraminidase on the sugar transport system in muscle tissue]. Sugars 32-37 neuraminidase 1 Homo sapiens 11-24 4506202-0 1972 Neuraminidase stimulates division and sugar uptake in density-inhibited cell cultures. Sugars 38-43 neuraminidase 1 Homo sapiens 0-13 28607101-5 2017 Addition of purified MsgA and NanA to the FBS resulted in a release of 2.8 mM galactose and 4.3 mM N-acetylneuraminic acid; these sugar concentrations were sufficient to upregulate the expression of ILY, MsgA, and NanA. Sugars 130-135 neuraminidase 1 Homo sapiens 30-34 28607101-5 2017 Addition of purified MsgA and NanA to the FBS resulted in a release of 2.8 mM galactose and 4.3 mM N-acetylneuraminic acid; these sugar concentrations were sufficient to upregulate the expression of ILY, MsgA, and NanA. Sugars 130-135 neuraminidase 1 Homo sapiens 214-218 381752-7 1979 An alternative explanation that these sugars are sterically accessible to galactose oxidase only after neuraminidase treatment also has to be considered. Sugars 38-44 neuraminidase 1 Homo sapiens 103-116